NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial.
about
Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients.The immune system and inflammation in breast cancer.Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants.Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3.
P2860
NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
NGlycolylGM3/VSSP Vaccine in M ...... of Phase I/IIa Clinical Trial.
@ast
NGlycolylGM3/VSSP Vaccine in M ...... of Phase I/IIa Clinical Trial.
@en
type
label
NGlycolylGM3/VSSP Vaccine in M ...... of Phase I/IIa Clinical Trial.
@ast
NGlycolylGM3/VSSP Vaccine in M ...... of Phase I/IIa Clinical Trial.
@en
prefLabel
NGlycolylGM3/VSSP Vaccine in M ...... of Phase I/IIa Clinical Trial.
@ast
NGlycolylGM3/VSSP Vaccine in M ...... of Phase I/IIa Clinical Trial.
@en
P2093
P2860
P356
P1476
NGlycolylGM3/VSSP Vaccine in M ...... of Phase I/IIa Clinical Trial.
@en
P2093
Adriana Car
Ana de la Torre
Carmen Viada
Darién Toledo
Elena García
Julio Hernandez
Kirenia Perez
Luis E Fernandez
Meylán Cepeda
Migdacelys Arboláez
P2860
P304
P356
10.4137/BCBCR.S8488
P577
2012-09-24T00:00:00Z